Legacy Trust’s Thermo Fisher Scientific TMO Stock Holding History

Legacy Trust’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.63M	Sell	3,326 -40	-1%	-$21.7K	0.31%	65
2025 Q4	$1.95M	Hold	3,366	–	–	0.36%	56
2025 Q3	$1.63M	Sell	3,366 -10	-0.3%	-$4.66K	0.32%	62
2025 Q2	$1.37M	Sell	3,376 -25	-0.7%	-$10.5K	0.34%	61
2025 Q1	$1.69M	Sell	3,401 -50	-1%	-$27.1K	0.41%	60
2024 Q4	$1.8M	Sell	3,451 -82	-2%	-$45.1K	0.42%	61
2024 Q3	$2.19M	Buy	3,533 +25	+0.7%	+$14.8K	0.5%	60
2024 Q2	$1.94M	Sell	3,508 -9	-0.3%	-$5.16K	0.48%	59
2024 Q1	$2.04M	Sell	3,517 -43	-1%	-$24.1K	0.51%	57
2023 Q4	$1.89M	Hold	3,560	–	–	0.49%	56
2023 Q3	$1.8M	Sell	3,560 -437	-11%	-$233K	0.52%	57
2023 Q2	$2.09M	Sell	3,997 -2	-0.1%	-$1.08K	0.57%	56
2023 Q1	$2.3M	Sell	3,999 -43	-1%	-$24.2K	0.69%	50
2022 Q4	$2.23M	Buy	+4,042	New	+$2.14M	0.69%	48

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Legacy Trust's TMO Position: Q1 2026 in Review

Legacy Trust reduced its Thermo Fisher Scientific (TMO) stake by 1.2% in Q1 2026, selling an estimated $21.7K and leaving 3,326 shares worth $1.63M. The position accounts for 0.31% of the portfolio, ranked #65.

Legacy Trust first reported a position in TMO in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.3M in Q1 2023. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Legacy Trust held 3,326 shares of Thermo Fisher Scientific worth $1.63M as of Q1 2026.
Legacy Trust sold 40 Thermo Fisher Scientific shares in Q1 2026, an estimated $21.7K.
Thermo Fisher Scientific made up 0.31% of Legacy Trust's portfolio in Q1 2026, its #65 holding.
Legacy Trust first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 14 quarters since.
Legacy Trust's Thermo Fisher Scientific position peaked at $2.3M in Q1 2023.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Legacy Trust's 13F filing for Q1 2026, filed 14 Apr 2026.